Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Tripling the dosage of the Wegovy weight-loss drug leads to more weight loss, Novo Nordisk said Friday.

Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...

WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...

The Biden administration on Friday released the next round of prescription drugs selected for Medicare price negotiations, ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

SEC sues Elon Musk over Twitter purchase, Microsoft says businesses should get quantum ready in 2025, and more news to start ...

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...

Also in today’s edition: ‘no-show’ international student data and significant progress in Israel-Hamas ceasefire talks ...

Consumers reported a 9.5% out-of-stock rate for foods in 2024. This figure dropped from 12.3% in 2023 and 19.3% in 2022, ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...